NCT02385422 arm group 26d2fbd6e63d0a9e8088f5c6543845ec [clinicaltrials_resource:NCT02385422/arm-group/26d2fbd6e63d0a9e8088f5c6543845ec]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02385422 arm group 26d2fbd6e63d0a9e8088f5c6543845ec [clinicaltrials_resource:NCT02385422/arm-group/26d2fbd6e63d0a9e8088f5c6543845ec]
Bio2RDF identifier
NCT02385422/arm-group/26d2fbd6e63d0a9e8088f5c6543845ec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... d2fbd6e63d0a9e8088f5c6543845ec
description [clinicaltrials_vocabulary:description]
Propranolol,30mg-160mg/d,oral,6 months
identifier
clinicaltrials_resource:NCT02385422/arm-group/26d2fbd6e63d0a9e8088f5c6543845ec
title
NCT02385422 arm group 26d2fbd6e63d0a9e8088f5c6543845ec
@en
type
label
NCT02385422 arm group 26d2fbd6 ...... 2fbd6e63d0a9e8088f5c6543845ec]
@en